Biotech Values

[biomaven0]

To date, 3 of 34 patients (9%) evaluable by RECIST achieved a confirmed partial response (PR)

I think that says more about RECIST than the drug. Results looks spectacular to me. Bone mets are likely the single most important problem for prostate cancer patients.

Peter